Clinical trial readiness in nemaline myopathy

6 – 8 September 2019

Clinical trial readiness in nemaline myopathy caused by mutations in the nebulin and actin (ACTA1) genes

Organisers: Prof. L. Servais (France), Prof. C. Wallgren-Pettersson (UK), Prof. C. Bönnemann (USA)

Venue

Courtyard Marriott Amsterdam Airport Hotel
Bosweg 15
2131 LX Hoofddorp
The Netherlands

Further details

The ERNs are co-funded by the
European Union (Health Programme and CEF)

EU Commission


“EURO-NMD is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Union (Health Programme and CEF).
For more information about the ERNs and the EU health strategy,
please visit ec.europa.eu/health/ern